GKCT brings to you the “5th Edition of Annual Review in Gastrointestinal Cancer” to be held on 22nd – 24th July 2022 on a Virtual Platform.
The primary goal of this meeting is to guide practicing physicians on integrating the best and most current evidence into day-to-day routine care for patients with GI cancers. This meeting brings a practical perspective on how to optimize multidisciplinary care for some of the more complex clinical management decisions. Topics discussed include locoregional modalities, the role of minimally invasive procedures, and state-of-the-art treatment.
As we are aware chemotherapy dependency has maintained its validity in several gastrointestinal cancers and continues to be successfully explored, especially in academic trials. However, a number of biomarkers currently guide treatment decisions for patients with gastrointestinal neoplasms. Major technological advances in genomics have made it possible to identify critical genetic alterations in cancer, rendering oncology well along the path to “personalized cancer medicine”.
Image-guided surgery & minimally invasive treatment has evolved over the past several decades, which has led to reduced local recurrence rates and improved survival outcomes. The approach to diagnosis, staging and selection of appropriate treatment modalities has become a multidisciplinary effort combining interventional endoscopy, surgery, and radiology tools that need to be discussed and implemented in our practice.
This meeting focuses on case-based and didactic presentations from national international experts in the treatment of the whole spectrum of gastrointestinal (GI) cancers, including esophageal, gastric, hepatocellular, pancreatic, small bowel, bile duct, anal and colorectal, and gallbladder. Our year-in review session, hallmark surgical video sessions and case-based panel discussion will provide an overview of exciting new research in the area of gastrointestinal tumours that may establish the stage for an innovative personalized management and precision medicine modalities for individualized care.
We are sure our attempt in understanding the various therapeutic interventions will pave the way for improved patient outcomes. We look forward to your active participation.